4//SEC Filing
Hamm Robert A 4
Accession 0001127602-10-005573
CIK 0000875045other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 2:55 PM ET
Size
7.1 KB
Accession
0001127602-10-005573
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Hamm Robert A
EVP, Pharma. Oper. & Tech.
Transactions
- Sale
Common Stock
2010-02-18$56.15/sh−3,194$179,358→ 26,333.41 total - Sale
Common Stock
2010-02-18$56.16/sh−3,387$190,198→ 22,946.41 total
Footnotes (4)
- [F1]Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- [F3]This represents the weighted average price for shares sold at a range between $55.90 (low) and $56.29 (high).
- [F4]This represents the weighted average price for shares sold at a range between $55.90 (low) and $56.33 (high).
Documents
Issuer
BIOGEN IDEC INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001335018
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 2:55 PM ET
- Size
- 7.1 KB